Local furniture factory, Mukilteo manufacturer, heard that there was a shortage in personal protective equipment (PPE) for doctors, nurses and respiratory therapists. Using the design from Providence St. Joseph Health’s 100 Million Mask Challenge, Mukilteo started making masks. You can hear more about this story on Komo News.
With Q2 results, Providence surpasses more than a year of profitability, fueled by focused restructuring and operational improvements
Grant‑funded collaboration focuses on mRNA vaccine technology to strengthen personalized T‑cell therapies for pancreatic cancer
An inside look at how a pharmacist at Providence Cancer Institute keeps clinical trials running safely, one dose at a time.
An expanded access program uses engineered T cells to target the KRAS G12D mutation in pancreatic, colorectal or other advanced cancers.
A new oral therapy is available for metastatic pancreatic cancer that has progressed after chemotherapy.
Brad Myers, PharmD, MBA, has been named Providence's new chief pharmacy officer.
Providence study reveals clinician burnout can be successfully addressed with empowerment and well-being leadership development training.
Amanda Chawla has been named as Providence's chief supply chain officer. Chawla will lead systemwide supply chain strategy and operations, helping strengthen resiliency and improve performance.
Mila Sprouse, chief nursing officer for the North Puget Sound service area, has been named a 2026 fellow with the American Academy of Nursing.
A new clinical trial is testing a promising drug combination that could improve survival for people whose cancer didn’t fully respond to standard treatment.
When Brad’s medullary thyroid cancer returned after a surgical procedure, he enrolled in a clinical trial. Now, his cancer is nearly undetectable.
PSNI collaborates with Seattle-based HDT Bio on preparations for trialing novel treatment to breach blood-brain barrier
Providence today received a Greenhealth Top Health System Award by Practice Greenhealth. The award is Practice Greenhealth’s highest honor for health systems.
Researchers at Earle A. Chiles Research Institute, a division of Providence Cancer Institute of Oregon, are helping shape the future of cancer care at the 2026 ASCO Annual Meeting in Chicago.
Published in JAMA Network Open, a new Providence study uses real-world data to show how AI ambient listening reduces documentation burden, improving efficiency and clinician focus on patient care.
Radiation exposure during TAVR procedures was low overall across nearly 9,000 cases performed at Providence from 2018 to 2022, according to a new Providence study.
Inside the IMA203 phase III trial enrolling patients at Providence Cancer Institute.
Providence is joining a nationwide, federally funded research project to develop a Large Health Behavior Model.